# Optimising the method to develop spheroids from MDA-MB-468 human triple negative breast cancer cells

**Authors:** Shaza M. Mohamedahmed, Muhamad Noor Alfarizal Kamarudin, Premdass Ramdas, Usha Sundralingam, Ammu K. Radhakrishnan

PMC · DOI: 10.1007/s11033-026-11451-4 · Molecular Biology Reports · 2026-01-24

## TL;DR

This study optimizes methods to grow 3D spheroids from a breast cancer cell line, finding that normoxic conditions and specific techniques produce the most consistent and biologically relevant models.

## Contribution

A novel workflow combining hanging-drop pre-aggregation with ULA-plates under normal oxygen yields compact, structurally stable spheroids with reliable gene expression.

## Key findings

- Spheroids grown under normoxic conditions showed better structural integrity and gene expression patterns.
- Hanging-drop pre-aggregation with ULA-plates produced the most compact and resilient spheroids.
- HIF1A and VEGFA were more highly expressed under normoxic conditions, indicating pseudo-hypoxic signaling.

## Abstract

Three-dimensional (3D) spheroid models are increasingly used to emulate the tumour microenvironment for preclinical drug screening. This study aimed to optimise and assess spheroid formation from MDA-MB-468 triple-negative breast cancer (TNBC) cells using hanging drop, liquid overlay, and rigid scaffold methods under normal oxygen (NOC) and low oxygen (LOC) culture conditions.

Spheroids were generated and characterised using bright-field microscopy with AnaSP morphometrics (sphericity, solidity, and perimeter). Gene expression of Epithelial-Mesenchymal Transition (EMT), stemness, and hypoxia/angiogenesis markers (CD44, HIF1A, VEGFA, TWIST1, SNAI1, and NES) was quantified using qPCR. The optimised model was further evaluated using field-emission scanning electron microscopy (FE-SEM) and Hoechst fluorescence.

A workflow combining hanging-drop pre-aggregation with ultra-low attachment (ULA) or agarose-coated plates under NOC produced consistent, compact spheroids. Scaffold cultures formed rapidly but showed size variability under NOC and LOC. Across methods, spheroids were less compact, and gene expression patterns deviated from expected hypoxic responses. HIF1A and VEGFA were more highly expressed under NOC, suggesting pseudo-hypoxic signalling and activation of angiogenesis-related pathways. CD44 and TWIST1 were upregulated in most spheroid types, whereas SNAI1 and NES exhibited condition- and method-specific variability.

Spheroids cultivated under normoxic conditions demonstrated enhanced structural integrity and transcriptional fidelity. Nonetheless, the study identified that the most compact and resilient spheroids were achieved through the use of hanging-drop pre-aggregation combined with ULA-plates under NOC. The enhanced structural integrity and transcriptional fidelity observed in these spheroids make them valuable models for studying cancer biology and drug responses.

The online version contains supplementary material available at 10.1007/s11033-026-11451-4.

## Linked entities

- **Genes:** CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291], SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615], NES (nestin) [NCBI Gene 10763]
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** NES (nestin) [NCBI Gene 10763] {aka Nbla00170}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291] {aka ACS3, BPES2, BPES3, CRS, CRS1, CSO}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** LOC (MESH:D000860), HD (MESH:D020427), necrotic (MESH:D009336), TNBC (MESH:D064726), BC (MESH:D001943), cancer (MESH:D009369), triple (MESH:C536008), hypoxic (MESH:D002534)
- **Chemicals:** penicillin (MESH:D010406), streptomycin (MESH:D013307), ethanol (MESH:D000431), O2 (MESH:D010100), N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid (MESH:D006531), formalin (MESH:D005557), Agarose (MESH:D012685), EEO (-), SU8000 (MESH:C001952), S (MESH:D013455), P (MESH:D010758)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** SI5-6 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_C7S9), MDA-MB-46 — Homo sapiens (Human), Type 2 diabetes mellitus, Induced pluripotent stem cell (CVCL_B5RU), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), MDA-MB-468 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0419), Mad-Mb-468 — Mus musculus (Mouse), Adenoma of the mouse pulmonary system, Cancer cell line (CVCL_S501), HTB-132 — Mus musculus (Mouse), Hybridoma (CVCL_A8FQ), ULA-NOC — Oncorhynchus mykiss (Rainbow trout), Spontaneously immortalized cell line (CVCL_L016), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), 2D — Mus musculus (Mouse), Hybridoma (CVCL_U038)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12831690/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12831690/full.md

---
Source: https://tomesphere.com/paper/PMC12831690